Real-world efficacy of a bivalent vaccine to prevent COVID-19 hospitalizations in non-hospitalized subjects
In a recent study published on Preprints by Lancet*researchers investigated the efficacy of a bivalent messenger ribonucleic acid (mRNA) booster of the 2019 coronavirus (COVID-19) vaccine in preventing severe outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Study: Efficacy of Bivalent mRNA Vaccine in Preventing Severe Outcomes of COVID-19: An Observational Cohort Study. …